Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness

Thorax

Volumn 61, Issue 12, 2006, Pages 1083-1090

  Hui, D S ^a   To, K W ^a   Ko, F W ^a   Fok, J P ^a   Chan, M C ^a   Ngai, J C ^a   Tung, A H ^a   Ho, C W ^a   Tong, M W ^a   Szeto, C C ^a   Yu, C M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EPWORTH SLEEPINESS SCALE; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; SLEEP TIME; SOMNOLENCE; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 33845200079     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.064063     Document Type: Article

References (42)

1. Engleman HM, Douglas NJ. Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004;59:618-22.
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
3. Ip MS, Lam B, Lauder IJ, et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 2001;119:62-9.
4. Hui DS, Chan JK, Ko FW, et al. Prevalence of snoring and sleep-disordered breathing in a group of commercial bus drivers in Hong Kong. Intern Med J 2002;32:149-57.
5. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea as a risk factor for hypertension: population study. BMJ 2000;320:479-82.
6. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000;283:1829-36.
7. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
8. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736-40.
9. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
10. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. Am J Respir Crit Care Med 2002;166:159-65.
11. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
12. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-14.
13. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
14. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
15. Engleman H, Martin S, Deary I, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnea/hypopnea syndrome. Lancet 1994;343:572-5.
16. Jenkinson C, Davies R, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized prospective parallel trial. Lancet 1999;353:2100-5.
17. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000;35:144-7.
18. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8.
19. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomised, controlled trial. Ann Intern Med 2001;134:1015-23.
20. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:773-80.
21. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 2002;359:204-10.
22. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
23. Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:656-64.
24. Robinson GV, Smith DM, Langford BA, et al. CPAP does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J 2006;27:1229-35.
25. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-90.
26. Fung JW, Li TS, Choy DK, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002;121:422-9.
27. Hui DS, Choy DK, Wong LK, et al. Prevalence of sleep-disordered breathing and CPAP compliance. Results in a group of Chinese patients post first-ever ischemic stroke. Chest 2002;122:852-60.
28. Hui DS, Chan JK, Choy DK, et al. Effects of augmented CPAP education and support on compliance and outcome in a Chinese population. Chest 2000;117:1410-6.
29. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service, Brain Information Institute, University of California, 1908.
30. American Sleep Disorders Association (ASDA). EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
31. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
32. Chung KF. Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J Psychosom Res 2000;49:367-72.
33. Heude E, Bourgin P, Feigel P, et al. Ambulatory monitoring of blood pressure disturbs sleep and raises systolic pressure at night in patients suspected of suffering from sleep-disordered breathing. Clin Sci (Lond) 1996;91:45-50.
34. Davies RJ, Jenkins NE, Stradling JR. Effect of measuring ambulatory blood pressure on sleep and on blood pressure during sleep. BMJ 1994;308:820-3.
35. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
36. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hr ambulatory blood pressure. Hypertension 2006;47:1-6.
37. Engleman HM, Martin SE, Deary IJ, et al. The effect of continuous positive airway pressure therapy on daytime function in the sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
38. George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12.
39. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea-Implications for cardiac and vascular disease. JAMA 2003;290:1906-14.
40. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.
41. Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 2004;27:934-41.
42. Douglas NJ, Engleman HM, Faccenda JF, et al. The science of designing ethical CPAP trials. Am J Respir Crit Care Med 2002;165:132-4.